Document:

Exhibit 4.4

 

SECOND SUPPLEMENTAL INDENTURE
 TO INDENTURE DATED AS OF AUGUST 15, 2003

 

SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of October 24, 2018, among Pepsi-Cola Metropolitan Bottling Company, Inc. (“Metro”) and Wells Fargo Bank, National Association, a national banking association (the “Trustee,” formerly known as Wells Fargo Bank Minnesota, National Association).

 

Capitalized terms not otherwise defined herein shall have the meanings set forth in the Indenture (as defined below).

 

WHEREAS, PepsiAmericas, Inc., the obligations of which were subsequently succeeded to by Metro, and the Trustee have heretofore executed and delivered a certain indenture, dated as of August 15, 2003 (as previously amended and as amended and supplemented hereby, the “Indenture”) providing for the issuance of Securities;

 

WHEREAS, pursuant to the Indenture, a series of 5.50% Notes due May 15, 2035 was issued by PepsiAmericas, Inc. on May 18, 2005, of which $250,000,000 in aggregate principal amount is currently outstanding (the “Outstanding Metro Notes”);

 

WHEREAS, pursuant to an Offer to Purchase and an Offering Memorandum, each dated October 11, 2018, as amended, PepsiCo, Inc. (“PepsiCo”) has respectively (i) offered to purchase for cash any and all Outstanding Metro Notes (the “Tender Offers”) and (ii) offered to exchange the Outstanding Metro Notes for new senior notes issued by PepsiCo (the “Exchange Offers,” and together with the Tender Offers, the “Offers”);

 

WHEREAS, pursuant to the Offers there have been obtained the consents (collectively, the “Required Consents”) of such proportion of the Holders of Outstanding Metro Notes as is required to approve a supplemental indenture to the Indenture to amend the Indenture as set forth in Article 1 of this Second Supplemental Indenture (the “Proposed Amendments”);

 

WHEREAS, Section 10.02 of the Indenture provides that with the consent of the Holders of not less than a majority in aggregate principal amount of the Securities of any series then Outstanding, Metro, when authorized by a Certified Board Resolution, and the Trustee may at any time and from time to time, enter into an indenture or indentures supplemental to the Indenture for the purpose of eliminating any of the provisions of the Indenture or modifying in any manner the rights of the Holders of Securities, subject to the limitations set forth therein;

 

WHEREAS, an Opinion of Counsel has been delivered to the Trustee to the effect that this Second Supplemental Indenture is authorized or permitted by the Indenture;

 

WHEREAS, Metro desires and has requested that the Trustee join in the execution of this Second Supplemental Indenture for the purpose of evidencing the implementation of the Proposed Amendments;

 

1

 

WHEREAS, the execution and delivery of this Second Supplemental Indenture have been authorized by resolutions of the board of directors of Metro; and

 

WHEREAS, all conditions precedent and requirements necessary to make this Second Supplemental Indenture a valid and legally binding instrument in accordance with its terms have been complied with, performed and fulfilled, and the execution and delivery hereof have been in all respects duly authorized;

 

NOW, THEREFORE, Metro and the Trustee agree as follows for the benefit of each other and for the equal and ratable benefit of the Holders.

 

Article 1
  Amendments to Indenture and Outstanding Metro Notes

 

Section 1.01. The Indenture is hereby amended as follows:

 

(a)                                 The following sections of the Indenture shall be deleted in their entirety and replaced with “RESERVED”:

 

(i)                                     Section 4.05. Limitation on Liens;

 

(ii)                                  Section 4.06. Limitation on Sale and Lease-Back;

 

(iii)                               Section 4.07. Exempted Indebtedness;

 

(iv)                              Section 4.09. Further Instruments and Acts; and

 

(v)                                 Section 5.03. Reports by Company.

 

(b)                                 Failure to comply with the terms of any of the foregoing Sections of the Indenture shall no longer constitute a Default or an Event of Default under the Indenture and shall no longer have any other consequence under the Indenture. Provisions in the Indenture that authorize action by the Company when permitted by a deleted section or which is to be done in accordance with a deleted section shall be deemed to permit such action and references in the Indenture to deleted provisions shall also no longer have any effect or consequence under the Indenture.

 

(c)                                  Section 1.01 of the Indenture is hereby amended to delete the following defined terms in their entirety: “Principal Property” and “Restricted Subsidiary.”

 

(d)                                 Section 1.02 of the Indenture is hereby amended to delete the following defined terms in their entirety (and also to delete the same in the places of the Indenture where they appear): “Consolidated Net Worth,” “Debt,” “Funded Debt,” “Liens,” “Minority Interest,” “Sale and Lease-Back Transaction” and “Value.”

 

(e)                                  Section 6.01 of the Indenture is hereby amended and restated in its entirety as follows:

 

2

 

SECTION 6.01. Events of Default. “Event of Default,” wherever used herein with respect to the Securities of any series, means any one of the following events which shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body):

 

(1)                                 default in the payment of any interest upon any of the Securities of such series when and as the same shall become due and payable, and continuance of such default for a period of 30 days;

 

(2)                                 default in the payment of all or any part of the principal of (or premium, if any, on) any of the Securities of such series at its Maturity;

 

(3)                                 default in the deposit of any sinking fund or analogous payment for the benefit of the Securities of such series when and as the same shall become due and payable;

 

(4)                                 default in the performance, or breach, of any covenant or warranty of the Company in the Securities of such series or in this Indenture (other than a covenant or warranty a default in whose performance or whose breach is elsewhere in this Section specifically provided for or which has expressly been included in this Indenture solely for the benefit of the Securities of other series), and continuance of such default or breach for a period of 90 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 51% in aggregate principal amount of the Securities of all series then Outstanding affected thereby a written notice specifying such default or breach, requiring it to be remedied and stating that such notice is a “Notice of Default” hereunder;

 

(5)                                 the entry by a court having jurisdiction in the premises of (a) a decree or order for relief in respect of the Company in an involuntary case or proceeding under any applicable Bankruptcy Law or (b) a decree or order adjudging the Company a bankrupt or insolvent, or appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or of all or substantially all of its property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree or order for relief or any such other decree or order unstayed and in effect for a period of 90 consecutive days;

 

(6)                                 the commencement by the Company of a voluntary case or proceeding under any applicable Bankruptcy Law or the consent

 

3

 

by it to the entry of a decree or order for relief in respect of the Company in an involuntary case or proceeding under any applicable Bankruptcy Law, or the consent by it to the appointment of or the taking of possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or of all or substantially all of its property, or the making by the Company of a general assignment for the benefit of creditors; or

 

(7)                                 any other Event of Default provided in or pursuant to the supplemental indenture or Officers’ Certificate establishing the terms of such series of Securities as provided in Section 2.01 or in the form or forms of Security for such series.

 

(f)                                   Section 11.01 of the Indenture is hereby amended and restated in its entirety as follows:

 

SECTION 11.01. Company May Consolidate, etc., on Certain Terms. The Company may consolidate with, or merge into, any Person, provided that in any such case, either the Company shall be the continuing Person, or the Person formed by such consolidation or into which the Company is merged shall expressly assume the due and punctual payment of the principal of (and premium, if any) and any interest on all the Securities, according to their tenor, and the due and punctual performance and observance of all of the covenants and conditions of this Indenture to be performed by the Company by supplemental indenture satisfactory to the Trustee, executed and delivered to the Trustee by such Person.

 

(g)                                  Section 11.02 of the Indenture is hereby amended and restated in its entirety as follows:

 

SECTION 11.02. Successor Corporation to Be Substituted. In case of any such consolidation or merger referred to in Section 11.01 and upon the assumption by the successor Person, by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the due and punctual payment of the principal of and interest on all of the Securities and the due and punctual performance of all of the covenants and conditions of this Indenture to be performed by the Company, such successor Person shall succeed to and be substituted for the Company, with the same effect as if it had been named herein as a party. Such successor Person thereupon may cause to be signed, and may issue either in its own name or in the name of PepsiAmericas, Inc. any or all of the Securities issuable hereunder which theretofore shall not have been signed by the Company and delivered to the Trustee; and, upon the order of such successor Person instead of the Company and subject to all the terms, conditions or limitations in this Indenture prescribed, the Trustee shall authenticate and shall deliver any Securities which previously should have

 

4

 

been signed and delivered by the officers of the Company to the Trustee for authentication, and any Securities which such successor Person thereafter shall cause to be signed and delivered to the Trustee for that purpose. All the Securities so issued shall in all respects have the same legal rank and benefit under this Indenture as the Securities theretofore or thereafter issued in accordance with the terms of this Indenture as though all of such Securities had been issued at the date of the execution hereof. In case of any such consolidation or merger referred to in Section 11.01, such changes in phraseology and form (but not in substance) may be made in the Securities thereafter to be issued as may be appropriate.

 

(h)                                 Section 11.03 of the Indenture is hereby amended and restated in its entirety as follows:

 

SECTION 11.03. Opinion of Counsel to Be Given Trustee. The Trustee, subject to Sections 7.01 and 7.03, shall be entitled to receive, and shall be fully protected in relying upon, an Opinion of Counsel stating that any such consolidation or merger and any such assumption complies with the provisions of this Article Eleven.

 

Section 1.02. Section 3 of the Outstanding Metro Notes is hereby amended such that the definitions of “Comparable Treasury Price,” “Redemption Treasury Dealer” and “Reference Treasury Dealer Quotations” are replaced with the following respective definitions:

 

“Comparable Treasury Price” means with respect to any Redemption Date for the Securities (i) the average of five Reference Treasury Dealer Quotations for such Redemption Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Independent Investment Banker obtains fewer than five such Reference Treasury Dealer Quotations, the average of all such quotations.

 

“Redemption Treasury Dealer” means each of any five primary U.S. government securities dealers in the United States of America selected by the Company.

 

“Reference Treasury Dealer Quotations” means, with respect to each Redemption Treasury Dealer and any Redemption Date, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Independent Investment Banker by such Redemption Treasury Dealer at 3:30 p.m. New York City time on the third Business Day preceding such Redemption Date.

 

5

 

Article 2
  Miscellaneous

 

Section 2.01. The recitals contained herein shall be taken as the statements of Metro and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of this Second Supplemental Indenture. The Trustee accepts the amendment of the Indenture effected by this Second Supplemental Indenture and agrees to perform the Indenture as supplemented hereby, but only upon the terms and conditions set forth in the Indenture.

 

Section 2.02. If any provision hereof limits, qualifies or conflicts with a provision of the Trust Indenture Act of 1939 (the “TIA”) that is required under the TIA to be part of and govern this Second Supplemental Indenture, the latter provision shall control. If any provision of this Second Supplemental Indenture modifies or excludes any provision of the TIA that may be so modified or excluded, the modified or excluded provision shall be deemed to apply to this Second Supplemental Indenture as so modified or to be excluded, as the case may be.

 

Section 2.03. Nothing in this Second Supplemental Indenture, express or implied, shall give to any Person, other than the parties hereto and their successors under the Indenture and the Holders, any benefit or any legal or equitable right, remedy or claim under this Second Supplemental Indenture.

 

Section 2.04. This Second Supplemental Indenture shall be deemed to be a contract under the laws of the State of Minnesota, and be governed by and construed in accordance with the laws of such state.

 

Section 2.05. This Second Supplemental Indenture may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument.

 

Section 2.06. Notwithstanding anything to the contrary elsewhere herein, this Second Supplemental Indenture shall become effective as of the Operative Date (as defined below). The “Operative Date” will occur upon the date on which PepsiCo shall have accepted for purchase or exchange sufficient Outstanding Metro Notes corresponding to the Required Consents pursuant to the Offers. Written notice of the Operative Date shall be promptly provided by Metro (or at Metro’s request by PepsiCo) to the Trustee.

 

IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly executed as of the day and year first written above.

 

6

 

	
 
    	
PEPSI-COLA   METROPOLITAN BOTTLING COMPANY, INC., as   successor-in-interest to PepsiAmericas, Inc.
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Ada Cheng
    
	
 
    	
 
    	
Name: Ada Cheng
    
	
 
    	
 
    	
Title: Vice President and Treasurer
    

 

	
 
    	
WELLS FARGO BANK, NATIONAL ASSOCIATION
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Tina D. Gonzalez
    
	
 
    	
 
    	
Name: Tina D. Gonzalez
    
	
 
    	
 
    	
Title: Vice President
    

 

[Signature page to Second Supplemental Indenture]

 

7sbph-ex101_11.htm

 

 

 

 

Exhibit 10.1

 

FIRST AMENDMENT TO LEASE

 

THIS FIRST AMENDMENT TO LEASE (this “First Amendment”) is made as of August 10, 2018 (the “Effective Date”) by and between 35 PARKWOOD REALTY LLC, a Massachusetts limited liability company (“Landlord”), and SPRING BANK PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”). 

WHEREAS, Landlord and Tenant entered into that certain Lease Agreement dated as of October 4, 2017 (the “Existing Lease”) with respect to approximately 19,446 rentable square feet of office space (the “Office Premises”) and approximately 10,037 rentable square feet of laboratory space (the “Lab Premises”) and approximately 1,832 rentable square feet of lab support space (the “Lab Support Premises;” collectively, the Office Premises, the Lab Premises and the Lab Support Premises are referred to herein as the “Premises”) in the building located at 35 Parkwood Drive, Hopkinton, Massachusetts (the “Building”), as more particularly described in the Existing Lease; and

 

WHEREAS, Landlord has performed certain work in the Office Premises (the “Office Work”) to prepare it for occupancy by Tenant, and is performing certain work in the Lab Premises (the “Lab Work”), each as shown on the plans and described on the scope of work attached to Exhibit D of the Existing Lease (collectively, the Office Work and the Lab Work are referred to herein as “Landlord’s Work”), and pursuant to the terms of the Existing Lease, the Term of the Lease is scheduled to commence upon substantial completion of Landlord’s Work; and

 

WHEREAS, Landlord completed the Office Work (including punch list items) and Tenant has been occupying the Office Premises since June 1, 2018 (the “Office Premises Commencement Date”), and Landlord and Tenant desire to revise the Existing Lease to: (a) commence the Term of the Lease with regard to the Office Premises on June 1, 2018, (b) Landlord completed the Lab Premises and Tenant has been occupying the Lab Premises since July 16, 2018 and the Landlord and Tenant desire to commence the Term with regard to the Lab Premises upon July 16, 2018 (the “Lab Premises Commencement Date”), as set forth in the Existing Lease, and (c) to commence the Term with regard to the Lab Support Premises on the Lab Premises Commencement Date;

NOW, THEREFORE, in consideration of the foregoing and for other consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as set forth below in this First Amendment.  Capitalized terms used in this First Amendment and not defined shall have their respective meanings set forth in the Existing Lease.

1.Existing Lease. The Existing Lease, as amended and affected by this First Amendment, is hereinafter referred to as the “Lease.”  As of the Effective Date, all references to the Lease in the Existing Lease shall mean the Existing Lease as amended by this First Amendment.

2.(a) Term Commencement for Office Premises, Lab Premises and Lab Support Premises.  Notwithstanding any provision of the Existing Lease to the contrary, including without limitation the definitions of “Term” and “Term Commencement Date” in the Basic Lease Information appended thereto, as of the Effective Date, for all purposes under the Lease, the Term shall be deemed to have commenced with regard to the Office Premises on the Office Premises Commencement Date.  As set 

 

 

 

 

 

forth in the Existing Lease and above in this First Amendment, the Term with regard to the Lab Premises shall commence upon the Lab Premises Commencement Date.  The Term with regard to the Lab Support Premises shall be deemed to have commenced for all purposes under the Lease on the Lab Premises Commencement Date. 

(b)Confirmation of Term and Rent Commencement Dates.  The Term Commencement Date of the Existing Lease shall be deemed to be June 1, 2018; the Rent Commencement Date of the Existing Lease shall be as set forth below in Section 3 of this First Amendment; the Term is scheduled to expire on October 31, 2028; and Tenant has the one-time right to terminate the Existing Lease effective October 31, 2027, provided that a Termination Notice and Termination Fee (as defined in Section 28 of the Existing Lease) must be delivered to Landlord on or before October 31, 2025. For the avoidance of doubt, this First Amendment shall eliminate the requirement in the Existing Lease that Landlord and Tenant execute and deliver Exhibit I to the Existing Lease, the Form of Confirmation of Term and Rent Commencement Dates. 

3.Basic Rent.  Tenant shall begin paying Basic Rent for the Office Premises on May 1, 2019, which is the first day following expiration of the 11-month rent abatement period set forth in the Existing Lease (the “Office Premises Rent Commencement Date”), and Basic Rent for the Lab Premises on the first day of the twelfth (12) month following the Lab Premises Commencement Date (the “Lab Premises Rent Commencement Date”).  As of the Effective Date, the two (2) tables in the Basic Lease Information section that provide the Basic Rent for the Office/Lab Premises and the Lab Support Premises shall be deleted and replaced with the three (3) tables below.

	
a.
	
Office Premises (19,446 rsf)

				
	
Period
	
Rental rate

per rsf
	
Annual

Fixed Rent
	
Monthly Fixed Rent

	
June 1, 2018 – April 30, 2019

Months 1 – 11
	
$0*
	
          $0
	
$0

	
May 1, 2019 – April 30, 2020

Months 12 - 23
	
$13.75
	
N/A

 
	
$22,281.87

	
May 1, 2020 – April 30, 2021

Months 24 - 35
	
$14.16
	
$275,355.36
	
$22,946.28

	
 

May 1, 2021 – April 30, 2022

 

Months 36 – 47

 
	
 

$14.58
	
 

$283,522.68
	
 

$23,626.89

	
 

May 1, 2022 – April 30, 2023

Months 48 – 59

 
	
 

$15.02
	
 

$292,078.92
	
 

$24,339.91

	
 

May 1, 2023 – April 30, 2024

Months 60 – 71

 
	
 

$15.40
	
 

$299,468.40
	
 

$24,955.70

	
 

May 1, 2024 – April 30, 2025

Months 72 – 83

 
	
 

$15.79
	
 

$307,052.34
	
 

$25,587.69

 

 

 

 

 

				
	
 

May 1, 2025 – April 30, 2026

Months 84 – 95

 
	
 

$16.18
	
 

$314,636.28
	
 

$26,219.69

	
 

May 1, 2026 – April 30, 2027

Months 96 – 107

 
	
 

$16.59
	
 

$322,609.14
	
 

$26,884.09

	
 

May 1, 2027 – April 30, 2028

Months 108 – 119

 
	
 

$17.00
	
 

$330,582.00
	
 

$27,548.50

	
May 1, 2028 - October 31, 2028

Months 120 – 125
	
$17.43
	
N/A
	
$28,245.31

 

	
b.
	
Lab Premises (10,037 rsf)

				
	
 

Period
	
Rental rate per rsf
	
Annual Fixed Rent
	
Monthly Fixed Rent

	
July 16, 2018 – June 15, 2019
	
$0*
	
$0
	
$0

	
June 16, 2019 – June 30, 2019
	
$13.75
	
N/A
	
$5,750.36

	
July 1, 2019 – April 30, 2020
	
$13.75
	
N/A
	
$11,500.73

	
May 1, 2020 – April 30, 2021

Months 24 - 35
	
$14.16
	
$142,123.92
	
$11,843.66

	
 

May 1, 2021 – April 30, 2022

Months 36 – 47

 
	
$14.58
	
$146,339.46
	
$12,194.95

	
 

May 1, 2022 – April 30, 2023

Months 48 – 59

 
	
$15.02
	
$150,755.74
	
$12,562.98

	
 

May 1, 2023 – April 30, 2024

Months 60 – 71

 
	
$15.40
	
$154,569.80
	
$12,880.82

	
 

May 1, 2024 – April 30, 2025

Months 72 – 83

 
	
$15.79
	
$158,484.23
	
$13,207.02

	
 

May 1, 2025 – April 30, 2026

Months 84 – 95

 
	
$16.18
	
$162,398.66
	
$13,533.22

	
 

May 1, 2026 – April 30, 2027

Months 96 – 107

 
	
$16.59
	
$166,513.83
	
$13,876.15

	
 

May 1, 2027 – April 30, 2028

Months 108 – 119

 
	
$17.00
	
$170,629.00
	
$14,219.08

	
May 1, 2028 - October 31, 2028

Months 120 – 125

 
	
$17.43
	
N/A
	
$14,578.74

 

 

 

 

 

c.Lab Support Premises (1,832 rsf)

				
	
 

Period
	
Rental rate

per rsf
	
Annual 

Fixed Rent
	
Monthly Fixed Rent

	
July 16, 2018 – June 15, 2019

 
	
$0
	
$0
	
$0

	
June 16, 2019- June 30, 2019
	
$6.00
	
N/A
	
$458.00

	
July 1, 2019 – April 30, 2020

 
	
$6.00
	
N/A
	
$916.00

	
May 1, 2020 – April 30, 2021

Months 24 - 35
	
$6.18
	
$11,321.76
	
$943.48

	
May 1, 2021 – April 30, 2022

Months 36 – 47
	
    $6.36
	
$11,651.52
	
$970.96

	
May 1, 2022 – April 30, 2023

Months 48 – 59

 
	
$6.55
	
$11,999.60
	
$999.97

	
May 1, 2023 – April 30, 2024

Months 60 – 71

 
	
$6.71
	
$12,292.72
	
$1,024.39

	
May 1, 2024 – April 30, 2025

Months 72 – 83

 
	
$6.88
	
$12,604.16
	
$1,050.35

	
May 1, 2025 – April 30, 2026

Months 84 – 95

 
	
$7.05
	
$12,915.60
	
$1,076.30

	
May 1, 2026 – April 30, 2027

Months 96 – 107

 
	
$7.23
	
$13,245.36
	
$1,103.78

	
May 1, 2027 – April 30, 2028

Months 108 – 119

 
	
$7.41
	
$13,575.12
	
$1,131.26

	
May 1, 2028 - October 31, 2028

Months 120 – 125

 
	
$7.59
	
N/A
	
$1,158.74

*Notwithstanding any portion of the three tables above, Tenant shall begin making payments of all sums other than Basic Rent due under the Lease, including without limitation, Additional Rent as set forth in Section 4(b) of the Existing Lease, as of the Office Premises Commencement Date and the Lab Premises Term Commencement Date.

 

 

 

 

 

4.Excluded Fixtures.  Pursuant to Section 22 of the Existing Lease, Exhibit A attached to this First Amendment shall hereby be incorporated into the Existing Lease. (Tenant to provide an Equipment List)  

5.Ratification.  Except as amended and modified by this First Amendment, all the terms, provisions, agreements, covenants and conditions of the Existing Lease are hereby affirmed and ratified.  From and after the Effective Date, all references to the “Lease” shall mean the Existing Lease as amended hereby, and to the extent that there any inconsistencies between this First Amendment and the Existing Lease, this First Amendment shall control.  

6.Execution/Entire Agreement.  This First Amendment, together with the Lease as affected hereby, constitutes the entire agreement of the parties, and may not be amended except by written instrument signed by all parties.  This First Amendment shall have the effect of an agreement under seal and shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.  This First Amendment may be executed in counterparts all of which taken together shall constitute an original executed document.

 

[Remainder of page intentionally left blank; signature page follows.]

 

 

IN WITNESS WHEREOF, the parties have executed this First Amendment as of the date first set forth above.

LANDLORD:

35 PARKWOOD REALTY, LLC,

a Massachusetts limited liability company

By:    /s/ John R. Parsons Jr.

Name:    John R. Parsons Jr.

Title:      Managing Member

 

TENANT:  

SPRING BANK PHARMACEUTICALS, INC.,

a Delaware corporation

 

 

By:  /s/ Jonathan Freve

Name:  Jonathan Freve

Title:    CFO

 Hereunto duly authorized

 

 

 

 

 

Exhibit A

Excluded Fixtures

 

Laboratory hoods and permanent benches

 

-7-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}]]